Editas Medicine (EDIT) Return on Equity [ROE] (2016 - 2025)
Editas Medicine's Return on Equity [ROE] was -1211.00% in Q3 2025, down 1107.70 percentage points from -103.31% a year earlier and down 635.90 percentage points from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Return on Equity [ROE] (2016 - 2025) Analysis & Trends
For FY2024, Return on Equity [ROE] at Editas Medicine came in at -98.10%, down 55.38 percentage points from FY2023.
- Return on Equity [ROE] shows a five-year change of -44.50 percentage points (FY2019 to FY2024).
- In earlier years, Return on Equity [ROE] was -42.72% in FY2023 (+5.50 pp), -48.22% in FY2022 (-7.56 pp), -40.65% in FY2021 (-0.34 pp) and -40.31% in FY2020 (+13.28 pp).
- The Q3 2025 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q1 2016.
- Compared with a year earlier, Return on Equity [ROE] has declined for six straight quarters, with an average year-over-year change of -245.66 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2021 (a gain of 32.24 percentage points); the worst was Q3 2025 (a drop of 1107.70 percentage points).
- Per Business Quant data, EDIT's Return on Equity [ROE] in the three quarters before Q3 2025 was -575.10% (Q2 2025), -255.01% (Q1 2025) and -153.01% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Editas Medicine | 239.69 Mn | -472.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,211.00% |
| Jun 30, 2025 | -575.10% |
| Mar 31, 2025 | -255.01% |
| Dec 31, 2024 | -153.01% |
| Sep 30, 2024 | -103.31% |
| Jun 30, 2024 | -73.49% |
| Mar 31, 2024 | -51.63% |
| Dec 31, 2023 | -42.73% |
| Sep 30, 2023 | -50.89% |
| Jun 30, 2023 | -56.93% |
| Mar 31, 2023 | -64.17% |
| Dec 31, 2022 | -56.85% |
| Sep 30, 2022 | -45.70% |
| Jun 30, 2022 | -37.72% |
| Mar 31, 2022 | -34.90% |
| Dec 31, 2021 | -33.77% |
| Sep 30, 2021 | -36.12% |
| Jun 30, 2021 | -26.92% |
| Mar 31, 2021 | -27.90% |
| Dec 31, 2020 | -31.68% |
API Access
Editas Medicine Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();